Bleumink GS - Search Results

1

Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study).

Bleumink GS, Rietveld I, Janssen JA, van Rossum EF, Deckers JW, Hofman A, Witteman JC, van Duijn CM, Stricker BH. Bleumink GS, et al. Am J Cardiol. 2004 Aug 1;94(3):384-6. doi: 10.1016/j.amjcard.2004.04.044. Am J Cardiol. 2004. PMID: 15276114

2

Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction.

Bleumink GS, van Duijn CM, Kingma JH, Witteman JC, Hofman A, Stricker BH. Bleumink GS, et al. Am Heart J. 2004 Apr;147(4):685-9. doi: 10.1016/j.ahj.2003.11.016. Am Heart J. 2004. PMID: 15077085

3

Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study.

Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH. Bleumink GS, et al. Eur Heart J. 2004 Sep;25(18):1614-9. doi: 10.1016/j.ehj.2004.06.038. Eur Heart J. 2004. PMID: 15351160

4

Genetic polymorphisms and heart failure.

Bleumink GS, Schut AF, Sturkenboom MC, Deckers JW, van Duijn CM, Stricker BH. Bleumink GS, et al. Genet Med. 2004 Nov-Dec;6(6):465-74. doi: 10.1097/01.gim.0000144061.70494.95. Genet Med. 2004. PMID: 15545741 Review.

5

Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects.

Schut AF, Bleumink GS, Stricker BH, Hofman A, Witteman JC, Pols HA, Deckers JW, Deinum J, van Duijn CM. Schut AF, et al. Among authors: bleumink gs. Eur Heart J. 2004 Dec;25(23):2143-8. doi: 10.1016/j.ehj.2004.08.026. Eur Heart J. 2004. PMID: 15571830

6

Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism.

Bleumink GS, Schut AF, Sturkenboom MC, van Duijn CM, Deckers JW, Hofman A, Kingma JH, Witteman JC, Stricker BH. Bleumink GS, et al. Pharmacogenet Genomics. 2005 Feb;15(2):75-81. doi: 10.1097/01213011-200502000-00003. Pharmacogenet Genomics. 2005. PMID: 15861031

7

C-reactive protein and risk of heart failure. The Rotterdam Study.

Kardys I, Knetsch AM, Bleumink GS, Deckers JW, Hofman A, Stricker BH, Witteman JC. Kardys I, et al. Among authors: bleumink gs. Am Heart J. 2006 Sep;152(3):514-20. doi: 10.1016/j.ahj.2006.02.023. Am Heart J. 2006. PMID: 16923423

8

Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study.

van Vark LC, Kardys I, Bleumink GS, Knetsch AM, Deckers JW, Hofman A, Stricker BH, Witteman JC. van Vark LC, et al. Among authors: bleumink gs. Eur Heart J. 2006 Oct;27(19):2346-52. doi: 10.1093/eurheartj/ehl230. Epub 2006 Sep 4. Eur Heart J. 2006. PMID: 16952920

9

Heart failure and incident late-life depression.

Luijendijk HJ, Tiemeier H, van den Berg JF, Bleumink GS, Hofman A, Stricker BH. Luijendijk HJ, et al. Among authors: bleumink gs. J Am Geriatr Soc. 2010 Aug;58(8):1441-8. doi: 10.1111/j.1532-5415.2010.02921.x. Epub 2010 Jun 1. J Am Geriatr Soc. 2010. PMID: 20533964

10

Nonsteroidal anti-inflammatory drugs and heart failure.

Bleumink GS, Feenstra J, Sturkenboom MC, Stricker BH. Bleumink GS, et al. Drugs. 2003;63(6):525-34. doi: 10.2165/00003495-200363060-00001. Drugs. 2003. PMID: 12656651 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters